|
Volumn 12, Issue 16, 2002, Pages 2205-2208
|
N-aryl-prolyl-dipeptides as potent antagonists of VLA-4
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PEPTIDE DERIVATIVE;
UNCLASSIFIED DRUG;
VERY LATE ACTIVATION ANTIGEN 4 ANATGONIST;
DIPEPTIDE;
VERY LATE ACTIVATION ANTIGEN 4;
ANIMAL EXPERIMENT;
ARTICLE;
CONTROLLED STUDY;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DESIGN;
DRUG HALF LIFE;
DRUG POTENCY;
DRUG SYNTHESIS;
NONHUMAN;
RAT;
ANIMAL;
BLOOD;
CHEMICAL STRUCTURE;
DRUG ANTAGONISM;
HALF LIFE TIME;
METABOLIC CLEARANCE RATE;
SPRAGUE DAWLEY RAT;
STRUCTURE ACTIVITY RELATION;
SYNTHESIS;
ANIMALS;
DIPEPTIDES;
HALF-LIFE;
INTEGRIN ALPHA4BETA1;
METABOLIC CLEARANCE RATE;
MOLECULAR STRUCTURE;
RATS;
RATS, SPRAGUE-DAWLEY;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 18444393997
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(02)00356-6 Document Type: Article |
Times cited : (16)
|
References (27)
|